NEW HAVEN — Yale New Haven Hospital (YNHH) recently completed its 750th liver transplant procedure, marking a major milestone in its mission to deliver life-saving care.
“Reaching 750 liver transplants is a testament to our team’s expertise and unwavering commitment to patient care,” said Dr. Hiroshi Sogawa, surgical director of liver transplantation at Yale New Haven Hospital and professor of surgery at Yale School of Medicine. “Every transplant represents a life saved and a family restored. We are proud to offer advanced techniques and compassionate care that make these outcomes possible.”
Nearly 106,000 people in the United States are waiting for an organ transplant. Options for organ donation are living organ donation and/or deceased organ donation. In 2024, more than 7,000 kidney and liver transplants were made possible by living donors. The YNHH Center for Living Organ Donors provides optimal donor care and support throughout the evaluation, donation, and recovery process.
“Our program’s success is built on collaboration and innovation,” said Joohyun Kim, PhD, transplant surgeon, Yale New Haven Health and Yale School of Medicine. “From living donor transplants to cutting-edge immunosuppressive protocols, we strive to set the standard for excellence in liver transplantation.”
Liver transplantation is often the only option for patients with end-stage liver disease or acute liver failure. Yale New Haven Hospital’s program is recognized nationally for its expertise in complex cases and its commitment to research and education. The team offers advanced techniques such as hypothermia therapy for the treatment of acute liver failure, as well as split, reduced and mono-segment liver transplantation.
